zolpidem has been researched along with Briquet Syndrome in 2 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, CI | 1 |
| Wang, SJ | 1 |
| Liu, CY | 1 |
| Thome, J | 1 |
| Ruchsow, M | 1 |
| Rösler, M | 1 |
| Becker, T | 1 |
2 other studies available for zolpidem and Briquet Syndrome
| Article | Year |
|---|---|
Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
Topics: Adolescent; Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed | 2009 |
[Zolpidem dependence and depression in the elderly].
Topics: Aged; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; H | 1995 |